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TO THE EDITOR
As epithelial appendages of the skin,
hair follicle/sebaceous glands (HF/SGs)
and eyelid meibomian glands (MGs) are
developmentally similar and share com-
mon characteristics including holocrine
differentiation, lipid secretion, and the
need for long-term proliferative capacity
and self-renewal (Knop et al., 2011).
Although the capacity for self-renewal
has been linked to the presence of
a quiescent adult stem cell pool in the
epidermis (Tumbar et al., 2004), cornea
(Cotsarelis et al., 1989), and intestine
(Pinto and Clevers, 2005), the loca-
tion and characterization of MG and
SG stem cells remain controversial. To
address this problem, we used a novel
three-dimensional (3D) reconstruction
technique, immunofluorescence tomo-
graphy, to identify label-retaining cells
(LRCs) using the H2B-GFP/K5tTA ‘tet-off’
mouse model (Tumbar et al., 2004) and
further characterize LRCs based on
expression of SOX9 and BLIMP1.
Eyelids from three mice killed at each
chase time point (n¼9) were embedded
in butyl-methyl methacrylate (BMMA),
serially sectioned at 2mm, and 3D
reconstructions generated according to
previous protocol (Parfitt et al., 2012).
Animals were treated according to the
ARVO statement on the use of animals
in vision research, and experiments
were approved by the IACUC of
the University of California, Irvine (P.I.
Jester, protocol no. 2,011–3,002,
approved 8 September 2011). After ima-
ging GFP, sections were sequentially
immunolabeled with CK6 (Abcam–
Cambridge, UK, no. ab24646), SOX9
(Millipore–Billerica, MA, no. Ab5535),
and BLIMP1 (Abcam no.ab96479) and
reimaged. Semi-automated alignment of
serial montage images and 3D recons-
truction was then carried out using
Amira software (Visage Imaging, San
Diego, CA). Finally, the total GFPþ
LRC count was quantified in three
high-resolution 3D reconstructions of
MGs and HF/SG at 28 (MG¼ 25±4;
HF/SG¼32±6), 42 (MG¼ 12±2; HF/
SG¼29±7), and 56-day (MG¼9±3;
HF/SG¼28±6) chase through physical
counting and ImageJ software (National
Institutes of Health, http://rsb.info.
nih.gov/ij/).
In Figure 1a, MG (encircled white)
and HF/SG (encircled yellow) skin
appendages of the eyelid are shown in
histological section. After 28-day doxy-
cycline chase, very few epithelial cells
retain GFP in the H2B-GFP/K5tTA
mouse MG (Figure 1b—red arrowhead)
compared with the HF (Figure 1b—
white arrowhead). In 3D (Figure 1c
and Supplementary Movie S1 online),
LRCs were observed at the transition
between CK6þ duct and acini epithe-
lium of the MG. In the HF/SG 3D
reconstruction (Figure 1D and Supple-
mentary Movie S2 online), LRCs are
restricted to the bulge region of the
HF, and no LRCs were detected in
the SG basal layer.
Quantification of total cells
(Figure 2a) and LRCs (Figure 2b) expres-
sing BLIMP1, SOX9, or CK6 in the MG
and HF was performed on eyelids
(n¼ 3) from mice euthanized at 56-day
doxycycline chase. SOX9 and BLIMP1
were found to be expressed in the
majority of MG and HF/SG epithelial
cells, whereas LRCs occupy only a small
population in these tissues. There was a
mean of 9±3 LRCs out of 4356±497
total cells per MG and a mean of 28±6
LRCs out of 573±95 total cells per
HF (Figure 2a). LRCs in the MG were
exclusively SOX9þ and BLIMP1 ,
whereas HF LRCs exhibited a variable
expression of SOX9 and BLIMP1
(Figure 2b). Slow-cycling MG cells
express SOX9 as do terminally differen-
tiated meibocytes (Figure 2c) and, in the
HF, SOX9 is present in differentiated
and quiescent cells (Figure 2d). In MGs,
the putative sebocyte progenitor marker,
BLIMP1, is absent in LRCs but present in
differentiated epithelial cells (Figure 2e).
BLIMP1 was found expressed in
differentiated HF cells, bulge LRCs,
and terminally differentiated sebocytes
(Figure 2f). MG LRCs were localized to
the ductal epithelium terminus where it
transitions to basal acinar epithelium
(Figure 2g) and infrequently express
CK6, whereas HF LRCs are exclusively
CK6 (Figure 2h).
Through immunofluorescence tomo-
graphy, we have localized and quanti-
fied a slow-cycling population of the
mouse MG found at the CK6þ ductule
that interconnects each acini with the
central duct. We hypothesize that turn-
over of the MG epithelia may be direc-
ted from these quiescent epithelial cells.
However, additional functional studies
are required to validate the potency of
these cells. In the HF, LRCs were
restricted to the bulge zone and none
were found in the SG basal layer in a
total of 6 glands evaluated. After loca-
lizing LRCs, we immuno-stained for
SOX9, a putative stem cell marker
(Formeister et al., 2009; Scott et al.,
2010) considered an essential adult
stem cell gene (Nowak et al., 2008). In
the HF and MG of the eyelid, quiescent
and differentiated cells express SOX9,
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and therefore our data indicate that
SOX9 is not a good marker of quies-
cent epithelial cells, although it still may
regulate stem cell quiescence as pre-
viously suggested (Nowak et al., 2008;
Kadaja et al., 2014).
Previous research also suggests that
the zinc-finger transcriptional repressor
BLIMP1 is a marker of a unipotent
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Figure 1. Immunofluorescence tomography of the H2B-GFP/K5tTA mouse eyelid after doxycycline chase. (a) Hematoxylin and eosin (H & E) staining of
BMMA-embedded mouse eyelid showing the meibomian gland (encircled white) and hair follicle/sebaceous gland (encircled yellow). Both the meibomian
gland (red arrowhead) and the hair follicle (white arrowhead) exhibit populations of slow-cycling epithelial cells after 28-day doxycycline chase. (c) In the
meibomian gland, the label-retaining cells (LRCs) are located at the ductule or ductal epithelium terminus where the acinus forms. (d) BLIMP1 is expressed
in differentiated hair follicle and sebaceous gland (SG) and is unlikely to be a marker of sebocyte progenitors. The hair follicle LRCs (green) are restricted
to the bulge region (b) and are absent in the SG. Scale bar¼ 50mm.
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Figure 2. Quantification of GFPþ label–retaining cells (LRCs) and the expression of BLIMP1, SOX9, and CK6 in the meibomian gland and hair follicle/sebaceous
gland after 56-day doxycycline chase. (a) The average total cell and (b) LRCs that express either SOX9, BLIMP1, or CK6 in the meibomian gland (blue) or
hair follicle (orange). (c–h) Immuno-staining of meibomian gland (c, e, and g—encircled white), hair follicle (d, f, and h—encircled yellow), and sebaceous
gland (f*—encircled red) showing co-localization of quiescent epithelial LRCs with (c and d) SOX9, (e and f), BLIMP1, and (g and h) CK6 in the H2B-GFP/K5tTA
mouse after 56-day doxycycline chase. Scale bar¼ 50mm.
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progenitor population that directs SG
turnover and sebocyte differentiation
(Horsley et al., 2006). However, our
high-resolution 3D data reveal that
BLIMP1 is expressed throughout the
HF in both quiescent and differentiated
HF cells and sebocytes. Furthermore,
BLIMP1þ cells located near or in the
SG were not found to be LRCs. This
finding supports a more recent study,
which found BLIMP1 in mature sebo-
cytes, (Sellheyer and Krahl, 2010),
raising important questions about the
role of BLIMP1 and the true identity of
sebocyte progenitor cells. The discovery
of a slow-cycling population offers
unprecedented insights into MG cell
turnover and may shed light on MG
age–related atrophy and dry eye disease.
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TO THE EDITOR
Over forty-one genetic susceptibility
loci of genome-wide significance
(Po5 108) are known for psoriasis,
a common complex genetic disease
characterized by epidermal hyperproli-
feration and cutaneous inflammation.
The most strongly associated of these
loci maps to the HLA-C gene in the
major histocompatibility complex
(MHC) on chromosome 6p21.3 (Zhang
et al., 2009; Tsoi et al., 2012). Recent
fine-mapping studies have identified
multiple independent association signals
in the MHC, and the strongest signal is
associated with HLA-C*06:02 (previous
designations: HLA-Cw6, HLA-Cw*0602)
or single-nucleotide polymorphisms
(SNPs) that are near-perfect surrogates
for this allele (Feng et al., 2009; Knight
et al., 2012; Das et al., 2014; Okada
et al., 2014). HLA-C*06:02 has been
known to be psoriasis-associated since
the 1970s, and most of the world
populations that have been studied
have shown strong evidence of asso-
ciation (Zhang et al., 2009; Stuart et al.,
2010; Shaiq et al., 2013; Okada et al.,
2014). Yet, it is difficult to perform a
routine affordable laboratory test for the
presence or absence of HLA-C*06:02,
because DNA-based testing is compli-
cated both by the high degree of
polymorphism of HLA-C (2375 alleles
encoding 1677 protein variations; July
2014 release of IMGT/HLA database;
Robinson et al., 2013) and by the
sequence similarity of HLA-C*06:02 to
other HLA-C as well as HLA-A and HLA-
B alleles. We previously used a seven-
SNP genotyping system to unam-
biguously define HLA-C*06:02 and
several other HLA-C alleles (Nair et al.,
2006). Others have used allele-specific
amplification followed by electro-
phoresis (Bunce et al., 1995), PCR
amplification followed by restriction
enzyme digestion (Tazi Ahnini et al.,
1999), a combination of four surrogate
SNPs that are amenable to Taqman
genotyping (Nikamo and Stahle, 2012),
and a three-SNP haplotype (rs1576-
rs130076-rs2523619) known to be in
strong linkage disequilibrium (LD) with
HLA-C*06:02 (Huffmeier et al., 2009).
Imputation of classical HLA alleles inclu-Accepted article preview online 10 December 2014; published online 8 January 2015
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nucleotide polymorphism
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